ABPI slams NICE International
August 20, 2012Sales and Marketing ABPI, NICE, NICE International, Romania, hta
The ABPI has expressed concerns over the remit of NICE International and its affect on global markets. NICE International is …
Pharma manufacturing news in brief
August 20, 2012Manufacturing and Production, Sales and Marketing Cambrex, GSK, Laureate, Morphotek
GlaxoSmithKline says it has shut down one of its two manufacturing facilities in India after offering all workers there early …
Roche winning on Perjeta supply, but running short of Boniva
August 20, 2012Manufacturing and Production, Sales and Marketing Boniva, Perjeta, Roche, breast cancer
Roche is getting production for its new breast cancer drug Perjeta back on track after some initial teething troubles, but …
Hospira hit by yet another product recall
August 20, 2012Manufacturing and Production, Sales and Marketing Carpuject, Hospira, overdose, recall
Generic pharma company Hospira has been forced to recall another product as it works to rectify quality issues at three …
Claris LifeSciences gets clean bill of health from FDA
August 20, 2012Manufacturing and Production, Sales and Marketing Claris, FDA, Pfizer, sterile
Indian drugmaker Claris LifeSciences seems to have set its house in order after manufacturing issues led the FDA to impose …
GSK severe asthma drug progresses to Phase III
August 20, 2012Research and Development, Sales and Marketing Advair, GSK, Phase II, asthma, phase III
GlaxoSmithKline’s severe asthma drug mepolizumab has impressed in a mid-stage study, meaning it can now progress into Phase III testing. …
Generic Actos gains FDA approval
August 20, 2012Sales and Marketing Actos, Mylan, Ranbaxy, Takeda, diabetes, generic
Takeda’s big-selling diabetes pill Actos will have its US sales decimated after the FDA approves three copycat versions of the …
Euro RSCG Life UK expands account services team
August 17, 2012Medical Communications Euro RSCG Life UK, Havas, Lucretia King
Euro RSCG Life UK, a leading healthcare communications network, is pleased to announce the appointment of Lucretia King as client …
Reynolds-MacKenzie appoints new leadership team
August 17, 2012Medical Communications Reynolds-Mackenzie
Reynolds-MacKenzie has made two new senior hires and an internal promotion to help drive its UK and international operations. The …
IPA Best of Health 2012 Awards highlights
August 17, 2012Medical Communications Best of Health, IPA, IPA Best of Health Awards, McCann Torre Lazur, advertising
McCann Torre Lazur and The Cement Bloc were awarded the prestigious ‘Best of Show’ awards at the 2012 IPA Best …
Xgeva gains NICE recommendation for bone metastasis
August 17, 2012Sales and Marketing Amgen, NICE, Xgeva, bone metastatis
NICE is continuing to recommend Amgen’s Xgeva for certain groups of cancer patients whose disease has spread to their bones. …
Zaicom MMC appoints new medical writer
August 17, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Katharine PeregrÃn, Zaicom MMC
Comms agency Zaicom MMC, part of the Zaicom International group of companies, has appointed Katharine PeregrÃn as a medical writer. …
Novartis eye drug succeeds in Phase III trial
August 16, 2012Sales and Marketing FDA, Novartis, Ocriplasmin, Roche, VMA
Novartis has posted positive results for its investigational eye drug ocriplasmin. The Phase III study found that ocriplasmin significantly resolved …
Pfizer meets targets on greenhouse gases
August 16, 2012Manufacturing and Production GHGs, Merck, Pfizer
Pfizer says it has fulfilled its goal of cutting environmentally-harmful emissions from its facilities by 20%, a year ahead of …
The number one reason for a failed project
August 16, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Communication, Failed project, Les Rose, clinical trials
There was once a company that had an amusing form of words for admonishing people. It went something like this: …
Boehringer posts strong financials
August 16, 2012Sales and Marketing AMNOG, Boehringer, COPD, Spiriva
Boehringer Ingelheim has seen steady growth in the first half of 2012, but warns that the next six months may …
Catalent Announces Commencement of Supply of Abilify® Orally Disintegrating Tablets to Otsuka and Extensive Investments to Zydis® Technology Capabilities in Swindon, UK
August 16, 2012Manufacturing and Production
Somerset, NJ, July 24, 2012 – Catalent announced it has commenced supply to Otsuka Pharmaceutical Co., Ltd. of Abilify® OD …
Catalent and Bend Research Partner to Provide Integrated Solutions for Oral Controlled-Release Technologies
August 16, 2012Manufacturing and Production
Catalent Pharma Solutions, Inc. and Bend Research Inc. have entered into an agreement to provide integrated solutions for pharmaceutical companies …
Diabetes prescriptions jump by 50% in England
August 15, 2012Sales and Marketing Humalog, Januvia, NHS, diabetes, spending
Diabetes prescriptions in England have for the first time topped 40 million this year, a rise of nearly 50% compared …
GSK sheds Australian generics unit for £172m
August 15, 2012Sales and Marketing Aspen Global, GSK, generics
GlaxoSmithKline has divested the majority of its Australian generics unit to Aspen Global, a firm it partly owns. The South …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
